| Title | Author(s) | Year | View Count |
 | Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay | Kao, RY; To, APC; Ng, LWY; Tsui, WHW; Lee, TSW; Tsoi, HW; Yuen, KY | 2004 | 154 |
| Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics | Kao, RY; Tsui, WHW; Lee, TSW; Tanner, JA; Watt, RM; Huang, JD; Hu, L; Chen, G; Chen, Z; Zhang, L; He, T; Chan, KH; Tse, H; To, APC; Ng, LWY; Wong, BCW; Tsoi, HW; Yang, D; Ho, DD; Yuen, KY | 2004 | 212 |
 | In vitro susceptibility of ten clinical isolates of SARS coronavirus to selected antiviral compounds | Chen, SF; Chan, KH; Jiang, Y; Kao, RYT; Lu, H; Fan, KW; Cheng, VCC; Tsui, WHW; Lee, TSW; Peiris, JSM; Yuen, KY | 2004 | 146 |
| In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds | Chen, F; Chan, KH; Jiang, Y; Kao, RYT; Lu, HT; Fan, KW; Cheng, VCC; Tsui, WHW; Hung, IFN; Lee, TSW; Guan, Y; Peiris, JSM; Yuen, KY | 2004 | 48 |
|
